Disposition of 194 shares by Christian Vasquez of BioatlaInc at 3.0 subject to Rule 16b-3
BCAB Stock | USD 1.64 0.07 4.46% |
About 80 percent of all Bioatla's investors are aggressively thinking of buying. The analysis of the overall investor sentiment regarding Bioatla suggests that quite a large number of traders are excited. The current market sentiment, together with Bioatla's historical and current headlines, can help investors time the market. In addition, many technical investors use Bioatla stock news signals to limit their universe of possible portfolio assets.
Bioatla |
Filed transaction by BioatlaInc Officer See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Bioatla's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Bioatla's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Bioatla Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Bioatla can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Bioatla Fundamental Analysis
We analyze Bioatla's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioatla using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioatla based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Bioatla is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Bioatla Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bioatla stock to make a market-neutral strategy. Peer analysis of Bioatla could also be used in its relative valuation, which is a method of valuing Bioatla by comparing valuation metrics with similar companies.
Peers
Bioatla Related Equities
IPSC | Century Therapeutics | 20.74 | ||||
CCCC | C4 Therapeutics | 8.59 | ||||
GLUE | Monte Rosa | 5.93 | ||||
ERAS | Erasca | 5.04 | ||||
RZLT | Rezolute | 4.18 | ||||
OLMA | Olema Pharmaceuticals | 4.12 | ||||
ADAG | Adagene | 4.05 | ||||
FHTX | Foghorn Therapeutics | 3.59 | ||||
NAUT | Nautilus Biotechnology | 2.68 | ||||
ACRV | Acrivon Therapeutics, | 2.31 | ||||
KYMR | Kymera Therapeutics | 1.91 | ||||
STTK | Shattuck Labs | 0.93 | ||||
PMVP | Pmv Pharmaceuticals | 0.63 | ||||
IKNA | Ikena Oncology | 1.17 | ||||
ANTX | AN2 Therapeutics | 1.44 | ||||
AVTE | Aerovate Therapeutics | 1.49 | ||||
NRIX | Nurix Therapeutics | 2.57 | ||||
DSGN | Design Therapeutics | 2.93 | ||||
PASG | Passage Bio | 10.67 |
Complementary Tools for Bioatla Stock analysis
When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |